Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0GCXCV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
WO2024140450A1 7-[N- (IP140B-Ac-PEG2-Gly-Gly-Leu-Gly-ha-Ac), N- (S)-methylisopropyl]aminoethyl-10,11-methylenedi-10,11-ethenyl-10,11-dihydroxycamptothecin
|
|||||
| Synonyms |
7-[N- (IP140B-Ac-PEG2-Gly-Gly-Leu-Gly-ha-Ac), N- (S)-methylisopropyl]aminoethyl-10,11-methylenedi-10,11-ethenyl-10,11-dihydroxycamptothecin
Click to Show/Hide
|
|||||
| Organization |
Hangzhou Adcoris Biopharmacy Co., Ltd
|
|||||
| Drug Status |
Investigative
|
|||||
| Structure |
|
|||||
| Antibody Name |
IP140B
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||